Skip to content

Symptom Assessment in Adolescents Placed on Child Welfare

Evaluation of Post-traumatic and Neurodevelopmental Symptoms in Adolescents Placed in Child Welfare

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07794332
Acronym
PePsAdoTND
Enrollment
200
Registered
2026-08-31
Start date
2026-01-30
Completion date
2028-03-01
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder (BPD), Complex Post-Traumatic Stress Disorder (CPTSD), Post-Traumatic Stress Disorder, PTSD

Brief summary

This study aims to characterize emotional dysregulation in complex post-traumatic stress disorder (cPTSD) and to determine the extent to which it can promote the distinction with borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD). As emotional dysregulation is a dynamic process whose phenomenological manifestations are labile, associated with physiological modifications and modulated by cognitive processing, a multiple methodology associating measurements in a real-life ecological context with measurements performed in the hospital will be preferred. Overall, this study proposes to capture, for the first time, the clinical manifestations associated with cPTSD from the perspective of emotional dysregulation and its underlying processes

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Adolescent aged 12 to 17 * Entrusted to ASE Bas-Rhin. * Fluent in French * Affiliated with a social health insurance scheme * Agreeing to take part in the study * Legal representative of the minor or his/her guardian, or his/her representative from the ASE agreeing to take part in the study.

Exclusion criteria

* Adolescent refusing to participate in the study * Legal representative of the minor or his/her guardian, or his/her ASE representative refusing to participate in the study * Adolescent with severe developmental delay * Adolescent participating in another research study * Adolescent deprived of liberty by judicial or administrative decision

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of post-traumatic stress disorder (PTSD) according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteriaFrom inclusion to the end (6 months)PTSD will be assessed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria, using the Child Post-Traumatic Checklist (CPC-P). The outcome will be the proportion of participants meeting DSM-5 diagnostic criteria for PTSD.
Prevalence of complex post-traumatic stress disorder (CPTSD) according to International Classification of Diseases, 11th Revision (ICD-11) criteriaFrom inclusion to 6 monthsComplex post-traumatic stress disorder (CPTSD) will be assessed according to the International Classification of Diseases, 11th Revision (ICD-11) diagnostic criteria, using the Child and Adolescent Trauma Screen (CATS). The outcome will be the proportion of participants meeting ICD-11 diagnostic criteria for CPTSD.

Countries

France

Contacts

CONTACTCarmen SCHRÖDER
carmen.schroder@chru-strasbourg.fr0033388115248

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026